1.With regard to joint scientific consultations on medical devices and in vitro diagnostic medical devices, the information referred to in Article 17(4) of Regulation (EU) 2021/2282 shall be provided by the JSC Subgroup via the HTA secretariat and shall, where applicable, include a timetable for the joint scientific consultation.